261 related articles for article (PubMed ID: 32348570)
1. Breast cancer patient advocacy: A qualitative study of the challenges and opportunities for civil society organizations in low-income and middle-income countries.
Dvaladze A; Kizub DA; Cabanes A; Nakigudde G; Aguilar B; Zujewski JA; Duggan C; Anderson BO; Pritam Singh RK; Gralow JR
Cancer; 2020 May; 126 Suppl 10():2439-2447. PubMed ID: 32348570
[TBL] [Abstract][Full Text] [Related]
2. Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women's Empowerment Cancer Advocacy Network (WE CAN) Summits.
Antone N; Kizub D; Gralow J; Zujewski JA; Dvaladze A
JCO Glob Oncol; 2021 Apr; 7():585-592. PubMed ID: 33891477
[TBL] [Abstract][Full Text] [Related]
3. Experiences of breast cancer survivor-advocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy.
Errico KM; Rowden D
Breast J; 2006; 12 Suppl 1():S111-6. PubMed ID: 16430394
[TBL] [Abstract][Full Text] [Related]
4. Civil society advocacy in Nigeria: promoting democratic norms or donor demands?
Williamson RT; Rodd J
BMC Int Health Hum Rights; 2016 Jul; 16(1):19. PubMed ID: 27400871
[TBL] [Abstract][Full Text] [Related]
5. Identifying important breast cancer control strategies in Asia, Latin America and the Middle East/North Africa.
Bridges JF; Anderson BO; Buzaid AC; Jazieh AR; Niessen LW; Blauvelt BM; Buchanan DR
BMC Health Serv Res; 2011 Sep; 11():227. PubMed ID: 21933435
[TBL] [Abstract][Full Text] [Related]
6. The role of civil society organizations (CSOs) in the COVID-19 response across the Global South: A multinational, qualitative study.
Levine AC; Park A; Adhikari A; Alejandria MCP; Bradlow BH; Lopez-Portillo MF; Mutwafy S; Zumbyte I; Heller P
PLOS Glob Public Health; 2023; 3(9):e0002341. PubMed ID: 37708149
[TBL] [Abstract][Full Text] [Related]
7. How donors support civil society as government accountability advocates: a review of strategies and implications for transition of donor funding in global health.
McDonough A; RodrÃguez DC
Global Health; 2020 Nov; 16(1):110. PubMed ID: 33183333
[TBL] [Abstract][Full Text] [Related]
8. A realist review of which advocacy interventions work for which abused women under what circumstances.
Rivas C; Vigurs C; Cameron J; Yeo L
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD013135. PubMed ID: 31254283
[TBL] [Abstract][Full Text] [Related]
9. Patient Advocacy Approaches to Improving Care for Breast and Cervical Cancer in East and Southern Africa.
Kizub DA; Zujewski J; Gralow JR; Ndoh K; Soko U; Dvaladze AL
JCO Glob Oncol; 2020 Feb; 6():49-55. PubMed ID: 32031438
[TBL] [Abstract][Full Text] [Related]
10. The role of breast cancer civil society in different resource settings.
Azenha G; Bass LP; Caleffi M; Smith R; Pretorius L; Durstine A; Perez CP
Breast; 2011 Apr; 20 Suppl 2():S81-7. PubMed ID: 21345677
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the management of breast cancer in low- and middle-income countries.
Yip CH; Taib NA
Future Oncol; 2012 Dec; 8(12):1575-83. PubMed ID: 23231519
[TBL] [Abstract][Full Text] [Related]
12. An Analysis of Contemporary Oncology Randomized Clinical Trials From Low/Middle-Income vs High-Income Countries.
Wells JC; Sharma S; Del Paggio JC; Hopman WM; Gyawali B; Mukherji D; Hammad N; Pramesh CS; Aggarwal A; Sullivan R; Booth CM
JAMA Oncol; 2021 Mar; 7(3):379-385. PubMed ID: 33507236
[TBL] [Abstract][Full Text] [Related]
13. Development of the 'REadiness SElf-assessment (RESEA) guide' to assist low and middle-income countries with establishing safe and sustainable radiotherapy services: a pragmatic sequential mixed qualitative methods project.
Donkor A; Luckett T; Aranda S; Vanderpuye V; Phillips JL
BMC Health Serv Res; 2021 Mar; 21(1):268. PubMed ID: 33757517
[TBL] [Abstract][Full Text] [Related]
14. Public-non-governmental organisation partnerships for health: an exploratory study with case studies from recent Ghanaian experience.
Hushie M
BMC Public Health; 2016 Sep; 16(1):963. PubMed ID: 27618964
[TBL] [Abstract][Full Text] [Related]
15. Experiences of barriers and facilitators to establishing and sustaining radiotherapy services in low- and middle-income countries: A qualitative study.
Donkor A; Luckett T; Aranda S; Vanderpuye V; Phillips J
Asia Pac J Clin Oncol; 2020 Apr; 16(2):e74-e85. PubMed ID: 32030881
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer in Sub-Saharan Africa: Challenges and Opportunities to Reduce Mortality.
Pace LE; Shulman LN
Oncologist; 2016 Jun; 21(6):739-44. PubMed ID: 27091419
[TBL] [Abstract][Full Text] [Related]
17. Exploring HIV/AIDS investigator perceptions of equity within research partnerships between low-and middle-income and high-income countries: a pilot survey.
Modlin CE; Kankaka EN; Chang LW; Sewankambo NK; Ali J
Health Res Policy Syst; 2023 May; 21(1):32. PubMed ID: 37127604
[TBL] [Abstract][Full Text] [Related]
18. Improving care for cancer-related and other forms of lymphoedema in low- and middle-income countries: a qualitative study.
Torgbenu E; Luckett T; Buhagiar M; Requena CM; Phillips JL
BMC Health Serv Res; 2022 Apr; 22(1):461. PubMed ID: 35395942
[TBL] [Abstract][Full Text] [Related]
19. Potential barriers to and facilitators of civil society organization engagement in increasing immunization coverage in Odukpani Local Government Area of Cross River State, Nigeria: an implementation research.
Etokidem A; Nkpoyen F; Ekanem C; Mpama E; Isika A
Health Res Policy Syst; 2021 Aug; 19(Suppl 2):46. PubMed ID: 34380517
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
